No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Information Technology Services
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application. The company serves technology, automotive, financial services, retail, government, and healthcare sectors. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Chatswood, Australia.
www.appen.comNo one on the platform currently holds APX.AX.
No tracked institution reports a position in APX.AX as of their last filing.
No one on the platform has traded APX.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 1.9% | -16.8% | ||||
| Profit Margin % | -9.5% | -19.7% | -5.5% | |||
| Free Cash Flow Margin % | 8.2% | -1.0% | 4.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $262M | +13.5% | $0.02 | $0.02–$0.03 | — | 1 |
| 2027 | $329M | +25.4% | $0.09 | $0.08–$0.09 | — | 2 |
| 2028 | $389M | +18.5% | $0.11 | $0.11–$0.11 | — | 2 |
| 2029 | $413M | +6.2% | $0.13 | $0.11–$0.15 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $-0.03 | $-0.02 | +37.8% |
| 2026-02-24 | $-0.03 | $-0.00 | +93.0% |
| 2024-08-29 | $-0.11 | $-0.12 | -5.5% |
| 2024-02-27 | $-0.12 | $-0.54 | -342.7% |
| 2023-08-29 | $-0.31 | $-0.45 | -44.0% |
| 2023-02-26 | $-0.12 | $-2.46 | -2030.1% |
| $67M |
| — |
| COS.AXCOSOL Limited | $0.19 | +0.00% | $35M | — |
| FND.AXFindi Limited | $0.41 | +0.00% | $24M | — |
Source: Financial Modeling Prep · peers by sector/industry